Loading…
Mesa Laboratories, Inc. is projected to rise to $125.62 by 2027, a +25% move from its current price of $100.81. MLAB is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $98.50 | $100.81 | $103.18 | 0.00% |
| Aug 3 | $97.56 | $100.81 | $104.18 | 0.00% |
| Aug 4 | $96.84 | $100.81 | $104.95 | 0.00% |
| Aug 5 | $96.24 | $100.81 | $105.61 | 0.00% |
| Aug 6 | $95.71 | $100.81 | $106.19 | 0.00% |
| Aug 7 | $95.24 | $100.82 | $106.71 | +0.01% |
| Aug 8 | $94.81 | $100.82 | $107.20 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $94.81 | $100.82 | $107.20 | +0.01% |
| Week 2 | $92.43 | $100.82 | $109.97 | +0.01% |
| Week 3 | $90.65 | $100.83 | $112.15 | +0.02% |
| Week 4 | $89.18 | $100.83 | $114.02 | +0.02% |
| Week 5 | $87.90 | $100.84 | $115.69 | +0.03% |
| Week 6 | $86.76 | $100.85 | $117.22 | +0.04% |
| Week 7 | $85.72 | $100.85 | $118.65 | +0.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Mesa Laboratories, Inc. is a technology-focused company that designs, manufactures, sells, and services life sciences tools and quality control products and services. It operates across North America, Europe, the Asia Pacific, and internationally, serving the pharmaceutical, medical device, and healthcare industries.
The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators used to assess sterilization, decontamination, disinfection, and cleaning processes, along with sterility assurance testing and laboratory services. The Biopharmaceutical Development segment develops automated systems for protein analysis and peptide synthesis solutions, while the Clinical Genomics segment provides MassARRAY and related consumables for DNA analysis in hereditary disease screenings, pharmacogenetics, oncology, and toxicology research. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in diverse applications.
Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Mesa Laboratories, Inc. trades with a current price of $99.44 and a market cap of $549.4M, ranking 2919 by market size. The stock sits within a framework of a multi-year forecast that shows upside potential, with 2026 averaging $99.44, and progressively higher averages thereafter.
A major floor 19.5% below — a decisive break under it would weaken the trend.
The nearest floor, 9.4% below — buyers have tended to step in here.
The nearest ceiling, 4.7% above — a clean break opens room to run.
A major ceiling 12.5% above — clearing it would confirm fresh momentum.
Key MLAB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MLAB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $100.08 | Buy | $100.19 | Buy |
| MA 10 | $99.16 | Buy | $99.43 | Buy |
| MA 20 | $97.72 | Buy | $98.96 | Buy |
| MA 50 | $100.56 | Buy | $98.99 | Buy |
| MA 100 | $97.03 | Buy | $96.86 | Buy |
| MA 200 | $89.48 | Buy | $94.12 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.44 | Neutral |
| Stoch RSI (14) | 92.79 | Sell |
| CCI (20) | 90.94 | Neutral |
| Williams %R (14) | -4.49 | Info |
| MACD (12,26,9) | 0.57 | Buy |
| ROC (12) | 6.47 | Buy |
| Bollinger %B (20,2) | 0.78 | Neutral |
| Stochastic %K (14) | 95.51 | Sell |
| TRIX (15) | -0.07 | Sell |
| Awesome (5,34) | 1.76 | Buy |
| Ultimate (7,14,28) | 59.76 | Neutral |
| Momentum (10) | 2.87 | Buy |
| Aroon Osc (25) | -12.00 | Sell |
| Hull MA (9) | 101.07 | Sell |
| ADX (14) | 7.69 | Neutral |
| ATR (14) | 2.01 | Info |
The 30-day technical picture is bullish, with RSI14 at 50. The near-term moving averages show a SMA50 of $101.29 and a SMA200 of $87.85, providing a framework for trend direction. Key levels include support at $91.36 and resistance at $109.13, defining the immediate trading range.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $73.23 | $100.81 | $130.16 | 0% | Neutral | |
| $101.55 | $125.62 | $163.42 | +25% | Bullish | |
| $122.40 | $155.04 | $208.38 | +54% | Bullish | |
| $149.75 | $193.40 | $266.66 | +92% | Bullish | |
| $166.92 | $219.29 | $308.92 | +118% | Bullish | |
| $178.93 | $238.73 | $342.68 | +137% | Bullish | |
| $193.01 | $261.23 | $381.34 | +159% | Bullish | |
| $201.35 | $276.20 | $409.41 | +174% | Bullish | |
| $249.63 | $346.80 | $521.35 | +244% | Bullish | |
| $299.60 | $421.29 | $641.68 | +318% | Bullish | |
| $418.23 | $621.05 | $999.48 | +516% | Bullish | |
| $767.79 | $1,250.08 | $2,181.02 | +11.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $73.23 | $100.81 | $121.54 | +0.00% |
| September 2026 | $84.78 | $99.86 | $120.66 | -0.94% |
| October 2026 | $85.16 | $100.89 | $123.01 | +1.03% |
| November 2026 | $87.97 | $104.71 | $128.62 | +3.79% |
| December 2026 | $88.06 | $105.26 | $130.16 | +0.52% |
Click any year to see its month-by-month MLAB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, MLAB could reach as high as $130.16, with a base case around $100.81 and support toward $73.23 — roughly 0% from $100.81. A consolidation phase looks the most probable path here.
Expect MLAB to range from $101.55 to $163.42 through 2027. The $125.62 average target implies a +25% move from current prices. That is up +25% on the projected 2026 average. Momentum favours further upside here.
The MLAB price prediction for 2028 points to an average of $155.04 (low $122.40, high $208.38) — a potential gain of +54% on today's $100.81. Buyers look set to stay in control over this stretch.
In 2029, MLAB is projected to trade between $149.75 and $266.66, averaging $193.40 — a potential gain of +92% from today's $100.81. That is up +25% on the projected 2028 average. Momentum favours further upside here.
Mesa Laboratories, Inc.'s 2030 outlook centres on $219.29, within a $166.92 to $308.92 range. That is up +13% on the projected 2029 average. That marks a +118% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, MLAB could reach as high as $342.68, with a base case around $238.73 and support toward $178.93 — roughly +137% from $100.81. Momentum favours further upside here.
Expect MLAB to range from $193.01 to $381.34 through 2032. The $261.23 average target implies a +159% move from current prices. That is up +9% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The MLAB price prediction for 2033 points to an average of $276.20 (low $201.35, high $409.41) — a potential gain of +174% on today's $100.81. Momentum favours further upside here.
In 2034, MLAB is projected to trade between $249.63 and $521.35, averaging $346.80 — a potential gain of +244% from today's $100.81. That is up +26% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Mesa Laboratories, Inc.'s 2035 outlook centres on $421.29, within a $299.60 to $641.68 range. That is up +21% on the projected 2034 average. That marks a +318% change versus current levels. Momentum favours further upside here.
By 2040, MLAB could reach as high as $999.48, with a base case around $621.05 and support toward $418.23 — roughly +516% from $100.81. Buyers look set to stay in control over this stretch.
Expect MLAB to range from $767.79 to $2,181.02 through 2050. The $1,250.08 average target implies a +11.4x move from current prices. That is up +101% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in MLAB today (≈ 9.919651 MLAB) could be worth
$12,400.34
+$11,400.34 (+1140%) by 2050 · US Dollar
Based on the average projected MLAB price of $1,250.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MLABwould be worth at today's price.
$1,000 invested in MLAB on Jul 31, 2025 (≈ 13.075313 MLAB) would be worth
$1,318.12
+$318.12 (+31.8%) today · 1.32× · US Dollar
Based on a MLAB entry price of $76.48 vs. today's $100.81.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $97.5 | $1,033.95 | +3.4% |
| 1 month ago | $104.39 | $965.71 | -3.4% |
| 3 months ago | $103.31 | $975.8 | -2.4% |
| 6 months ago | $80.5 | $1,252.3 | +25.2% |
| 1 year ago | $76.48 | $1,318.12 | +31.8% |
| All time (5.0y) ago | $289 | $348.82 | -65.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MLAB forecast.
Our base-case forecast reaches $200.00 around 2030.
Implied market cap at $200.00: $1.12B
The multi-year forecast shows a clear path of appreciation. In 2026 the average is $99.44 with a 0% ROI (neutral). From 2027 onward, the averages rise—$124.94 in 2027 (ROI 25.6%), $156.15 in 2028 (ROI 57%), $193.25 in 2029 (ROI 94.3%), and $224.57 in 2030 (ROI 125.8%), with continued gains through 2031 ($237.77, ROI 139.1%), 2032 ($251.90, ROI 153.3%), 2033 ($274.74, ROI 176.3%), 2034 ($350.60, ROI 252.6%), 2035 ($422.94, ROI 325.3%).
The forecast extends to 2040 ($622.87 avg, ROI 526.4%) and 2050 ($1,213.89 avg, ROI 1120.7%), all indicating bullish sentiment. These are estimates and not guarantees, and actual results may differ due to market and other risks.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $224.57 with a min of $164.94 and a max of $330.06, and a ROI of 125.8%, with bullish sentiment expected in that year.
Forecasts indicate bullish sentiment from 2027 onward, with 2027 avg $124.94 (ROI 25.6%), 2028 avg $156.15 (ROI 57%), 2029 avg $193.25 (ROI 94.3%), and rising further to 2030 avg $224.57 (ROI 125.8%) and beyond, though these are estimates and not guarantees.
Yes. The forecast max reaches $556.28 in 2034, exceeding $500; prior extremes show a max of $330.06 in 2030 and later a max of $1,070.01 in 2040 and $2,288.80 in 2050.
Current price is $99.44 and market cap is $549.4M.
Bullish sentiment with RSI(14) at 50; SMA50 is $101.29 and SMA200 is $87.85. Support is at $91.36 and resistance at $109.13, with a 30-day range from $82.25 to $120.22.
Mesa Laboratories, Inc. Community Discussion
0Share your Mesa Laboratories, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.